Barclays analyst Emily Field maintained a Hold rating on GlaxoSmithKline (GSK – Research Report) today and set a price target of £14.50. The ...

NEW YORK CITY, NY / ACCESS Newswire / March 28, 2025 / Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, ...

UTI sufferers have a new treatment option—and it's the first new class of antibiotics the FDA has approved for urinary tract ...

The drug is a needed new option for treating uncomplicated UTIs, a common infection that’s becoming harder to treat as rates ...

The drug Blujepa, from drugmaker GSK, provides a new treatment option as bacteria increasingly become resistant to the ...

After every meal, the intestines perform an action called peristalsis - moving food through their hollow interiors with coordinated contractions and relaxations of the smooth muscle.

GSK PLC closed 18.56% short of its 52-week high of £18.24, which the company achieved on May 16th.

ZURICH (Reuters) -Swiss drugmaker Roche has abandoned global diverse workforce targets and compatriot Novartis is ending its ...

Following Pfizer's disposal, BlackRock Investment Management (UK) Ltd, a unit of BlackRock, will become Haleon's largest ...

The total sale represents 7.3% of the issued share capital of Haleon, which was created by the merger of GSK and Pfizer's ...

"What we are trying to do is put you out of business and bankrupt you,” said conservative strategist Steve Bannon.

Global and Fortune 500 companies and world-class real estate portfolios recognized for catalyzing people-first places and organizations in 2024 Barclays, CBRE, Cisco, Citi Global, EDGE Technologies, ...